611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Toxins in Home Furnishings Can Be Passed on to KidsKratom-Related Poisonings Are Soaring, Study FindsFDA Aims to Strengthen Sunscreen RulesBrain Condition CTE Seen in H.S. Football Players: StudyPregnant Women Should Delay Gallbladder Surgery, Study FindsGut Microbes May Help Drive Lupus, Study FindsMost Hip, Knee Replacements Last Decades, Study FindsAHA News: Living Near Convenience Stores Could Raise Risk of Artery-Clogging ConditionPossible Parkinson's 'Pandemic' Looms: Report'Apple-Shaped' Body? 'Pear-Shaped'? Your Genes May TellProtect Your Aging Eyes From Macular DegenerationKidney Failure Patients Face Higher Risk of Cancer DeathHow Inactivity and Junk Food Can Harm Your BrainTattooed and Need an MRI Scan? What You Need to KnowGot the Flu? You Probably Shouldn't Head to the ERStudy Reaffirms Safety of Hepatitis C Meds in Liver Cancer PatientsSmart Steps for Healthy FeetOpioids Overprescribed for Common Children's Fracture, Study SaysNew Hepatitis Meds Are Saving Lives: StudyGun Injuries Bring Especially Tough RecoveriesAspirin Can Help Prevent Colon Cancer, But Many at Risk Don't Take ItAre Scientists Closer to Growing Made-to-Order Kidneys?Worldwide, More Die After Surgery Than From HIV, Malaria: StudyBlood Thinning Drug May Be Safer Option Against Recurrent StrokeStudy Ties Cancer-Causing HPV to Heart Disease, TooDangerous Bacteria May Lurk in Hospital SinksAs U.S. Measles Outbreaks Spread, Why Does 'Anti-Vax' Movement Persist?Cablivi Approved for Rare Clotting DisorderNew Antibiotic Treats Pneumonia, Skin InfectionsOpioid OD Deaths Are Saving Lives Through TransplantationHealth Tip: Know Your Family's Medical HistoryAHA News: High Blood Pressure Top Risk Factor for Stroke in Young AdultsRethinking Blood Pressure ReadingsPsoriasis Meds Might Help Fight Heart Trouble, TooSurgery Restores Movement to Kids With Polio-Like IllnessYou've Fainted. How Long Do You Need to Stay in the ER?Could Germs in Your Gut Send You Into Depression?Health Tip: Prevent the Spread of Head LiceExercise Your Right to Fight DiseaseObesity-Linked Cancers On the Rise Among Young AmericansUnraveling the Mystery of HiccupsAHA: 7 Things That Can Affect the Heart -- And What to Do About ThemStatins Help the Heart, No Matter What Your AgeFirst Generic Version of Advair Diskus Approved for Asthma, COPDMore Smoking, Heart Woes Boost Native Americans' Stroke RiskNearly Half of American Adults Have Unhealthy Hearts: ReportHealth Tip: Avoid Winter Skin RashesHow to Prevent and Treat Eye AllergiesPolar Vortex Brings Frostbite Danger: Protect YourselfAHA: Could a Heart Attack or Stroke Lead to Early Menopause?
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Drug for Spinal Muscular Atrophy May Help Older Children: Study

HealthDay News
by -- Robert Preidt
Updated: Aug 29th 2018

new article illustration

WEDNESDAY, Aug. 29, 2018 (HealthDay News) -- A drug used to treat a rare and deadly muscle-wasting disease in children still improves muscle control even if treatment begins at a later age, a new study found.

Spinal muscular atrophy (SMA) is a leading genetic cause of death in infants worldwide. It attacks nerve cells in the spinal cord, leading to muscle weakness, which can affect breathing, swallowing, walking and head control.

SMA type 1 is the most common and severe form of the disease. It starts before 6 months of age, with infants never gaining the ability to sit up. The median survival rate is eight to 14 months. That means half have shorter lives, half longer.

Previous studies focused on children 7 months old or younger.

This new study included 33 children, ages 8 months to 8 years, with SMA type 1. They were given an injection of the drug nusinersen (Spinraza) into the spinal canal.

The drug increases production of a protein essential for motor neurons in the spinal cord to survive. It was approved by the U.S. Food and Drug Administration in December 2016, and is the first and only approved treatment for all types of SMA.

Six months after the injection, all 33 children had significant muscle control improvements, even the oldest, the researchers reported.

Five patients, ranging from 18 months to 4 years of age when they got their first injection, were able to sit up without support for the first time.

The study was published Aug. 29 in the online issue of the journal Neurology.

"This study is exciting because we found participants had motor function improvement six months after receiving treatment, even an 8-year-old participant," study author Dr. Laurent Servais said in a journal news release.

Servais is a pediatric neurologist at Pitie-Salpetriere Hospital in Paris, France, and Citadelle Hospital in Liege, Belgium.

"The overall response was to the same extent as that in the previously studied younger population," he noted.

"Spinal muscular atrophy type 1 is a devastating disease, and it is encouraging to see that nusinersen may also help people who are at a later stage in the disease process," Servais said.

More research is needed, he said, to find out if genetic factors affect differences in patients' response to treatment.

More information

The Muscular Dystrophy Association has more on spinal muscular atrophy.